Rheumatoid arthritis and cardiovascular disease associations in the UK Biobank

Janek Salatzki1,2, Dorina-Gabriela Condurache1,3, Stefania D'Angelo4

  • 1William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, Charterhouse Square, London, EC1M 6BQ, UK.

BMC Medicine
|November 4, 2025
PubMed

Insights

Rheumatoid arthritis (RA) patients face increased risks for various cardiovascular diseases (CVDs), including heart attack and arrhythmias. Evidence suggests a potential causal link between RA and these conditions, independent of other risk factors.

Area of Science:

  • Cardiovascular health
  • Rheumatology
  • Genetic epidemiology

Background:

  • Rheumatoid arthritis (RA) is an autoimmune disease with known links to cardiovascular disease (CVD).
  • Understanding the precise nature and causality of this relationship is crucial for patient management.

Purpose of the Study:

  • To investigate observational and causal associations between rheumatoid arthritis (RA) and cardiovascular diseases (CVDs).
  • To explore potential links between RA and cardiac imaging phenotypes.

Main Methods:

  • Utilized UK Biobank data, defining RA through hospital records, self-reports, and medications.
  • Assessed associations between RA and prevalent/incident CVDs using logistic and Cox regression.
  • Employed two-sample Mendelian randomization to infer causal relationships, analyzing genetic data for RA, CVDs, and cardiac magnetic resonance (CMR) phenotypes.

Main Results:

  • RA cases (1,436) and controls (476,975) showed RA patients had higher risks for incident CVDs, notably pericardial disease, heart failure, and acute myocardial infarction (AMI).
  • Mendelian randomization supported causal links between RA and AMI, arrhythmias, and ischemic heart disease (IHD).
  • No significant associations were found between RA and cardiac magnetic resonance (CMR) imaging metrics.

Conclusions:

  • Individuals with rheumatoid arthritis (RA) exhibit an elevated risk for multiple prevalent and incident cardiovascular diseases (CVDs).
  • These heightened risks persist independently of shared risk factors, with evidence suggesting causal pathways for ischemic heart disease (IHD), acute myocardial infarction (AMI), and arrhythmias.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...